SCHEMBL21882473

SCHEMBL21882473

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(Oc4ccc(-c5cc(-c6ccccn6)cc(-c6ccccn6)c5)cc4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HSD17B10 Q99714 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
KLF5 Q13887 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
MAPK1 P28482 2/20 0.45
BLM P54132 1/20 0.45
MCL1 Q07820 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25985495 1.00 MAPT (0.46) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL21882439 0.97 TDP1 (0.49) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL21882396 0.94 MAOA (0.50) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL20220350 0.92 CYP1A2 (0.50) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL21882472 0.91 CYP1A2 (0.51) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL18327602 0.89 KDM4E (0.52) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL18327591 0.89 KDM4E (0.52) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL21882415 0.88 MAPK1 (0.55) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL18327558 0.88 KDM4E (0.53) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL9959506 0.88 KDM4E (0.53) MAPTALDH1A1KDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11730009-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. 2023-08-15 US disclosed
US-11730009-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. 2023-08-15 US disclosed
EP-3330265-B1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11730009-B2 Compound and organic light-emitting element comprising same CRY2, CRY1, NR2E3 MAPT 370/4885ALDH1A1 313/4885KDM4E 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.